Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-21 · accession 0001193125-25-291670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-21 | 2025-11-21 | LMAT | O'Connor John James | Dir | M - OptEx | $37.29 | +7,500 | 64.8K | +13% | +$279.7K |
| D | 2025-11-21 | 2025-11-21 | LMAT | O'Connor John James | Dir | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-21 | M | A | 7,500 | $37.29 | 64,801 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-11-21 | M | D | 7,500 | $0.00 | 0 | D | $37.29 · 2020-12-02 to 2025-12-02 | 7,500 Common Stock | (F2) This option is fully vested and exercisable. |